Cancer Cytopathology

Papers
(The H4-Index of Cancer Cytopathology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Tumor mutational burden on cytological samples: A pilot study39
HPV persistence after cervical surgical excision of high‐grade cervical lesions36
Evidence‐based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology33
A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens28
Assessment of risk of malignancy by application of the proposed Sydney system for classification and reporting lymph node cytopathology27
Cytologic diagnosis of metastatic melanoma by FNA: A practical review23
Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology22
Diagnostic mesothelioma biomarkers in effusion cytology20
Evaluation of the diagnostic accuracy of bronchial brushing cytology in lung cancer: A meta‐analysis19
Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from China19
Cervical cytology screening facilitated by an artificial intelligence microscope: A preliminary study19
Secretory carcinoma of the salivary gland, a rare entity: An international multi‐institutional study19
Accuracy of parotid gland FNA cytology and reliability of the Milan System for Reporting Salivary Gland Cytopathology in clinical practice19
Oral brush biopsy using liquid‐based cytology is a reliable tool for oral cancer screening: A cost‐utility analysis17
Evaluating the role of Z‐stack to improve the morphologic evaluation of urine cytology whole slide images for high‐grade urothelial carcinoma: Results and review of a pilot study17
How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid‐based cytology: Role of TERT promoter and BRAF V600E mutation a17
Application of deep learning as an ancillary diagnostic tool for thyroid FNA cytology16
The American Thyroid Association (ATA) integrates molecular testing into its framework for managing patients with anaplastic thyroid carcinoma (ATC): Update on the 2021 ATA ATC guidelines16
RAS mutation and associated risk of malignancy in the thyroid gland: An FNA study with cytology‐histology correlation16
Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine‐needle aspirates: A quality‐assurance metric for evaluating diagnostic performance in a cytopathology laboratory16
0.11734104156494